SCHEMBL20059958

SCHEMBL20059958

CCCc1ccc(OCC(=O)OCC)c(C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.57
PPARA Q07869 2/20 0.50
PPARG P37231 1/20 0.50
ALDH1A1 P00352 3/20 0.48
ABCB1 P08183 1/20 0.47
FFAR4 Q5NUL3 2/20 0.47
KDM4E B2RXH2 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MEN1 O00255 1/20 0.46
CASP1 P29466 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
FFAR1 O14842 1/20 0.46
TSHR P16473 1/20 0.45
ADRB3 P13945 2/20 0.45
CASP3 P42574 1/20 0.44
CASP7 P55210 1/20 0.44
CASP9 P55211 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6813642 0.89 ESR1 (0.52) ESR1PPARAPPARGALDH1A1ABCB1
SCHEMBL3689530 0.87 ESR1 (0.51) ESR1PPARAPPARGALDH1A1ABCB1
SCHEMBL14526028 0.87 ESR1 (0.55) ESR1ALDH1A1ABCB1KDM4EHPGD
SCHEMBL5522834 0.85 ESR1 (0.54) ESR1ALDH1A1ABCB1KDM4EHPGD
SCHEMBL14526030 0.85 ESR1 (0.54) ESR1ALDH1A1ABCB1KDM4EHPGD
SCHEMBL14526024 0.82 ESR1 (0.52) ESR1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL6503348 0.81 ESR1 (0.59) ESR1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL29843916 0.81 ESR1 (0.59) ESR1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13133449 0.81 ESR1 (0.47) ESR1ALDH1A1FFAR4MEN1KMT2A
SCHEMBL14526022 0.80 S1PR2 (0.57) ESR1PPARAPPARGALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794556-B1 BIS-(ARYL/HETEROARYL)-METHYLENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR TREATING CANCER GLEASON JAMES L (CA) 2018-04-18 EP disclosed